Archives of Neurology

• 

  Publication Venue For

  • Methodological remarks concerning the recent meta-analysis of carotid artery stenting vs carotid endarterectomy..  68:543-544. 2011
  • Persistence With Stroke Prevention Medications 3 Months After Hospitalization.  67:1456-1463. 2010
  • Apolipoprotein E ε4 status and cognitive decline with and without dementia - Reply.  67:1036-1037. 2010
  • An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease..  67:536-541. 2010
  • Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease..  65:45-53. 2008
  • Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease..  64:576-580. 2007
  • Antihypertensive medication use and incident Alzheimer disease: the Cache County Study..  63:686-692. 2006
  • Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database..  63:299-300. 2006
  • Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment..  63:97-101. 2006
  • Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1..  62:1904-1908. 2005
  • Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism..  62:917-921. 2005
  • A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study..  62:241-248. 2005
  • Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis - Optic Neuritis Study Group.  61:1538-1541. 2004
  • Neurologic impairment 10 years after optic neuritis - Optic Neuritis Study Group.  61:1386-1389. 2004
  • Neurologic impairment 10 years after optic neuritis..  61:1386-1389. 2004
  • Traumatic neuroma diagnosed by ultrasonography..  61:1322-1323. 2004
  • Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial..  61:1044-1053. 2004
  • Self- or proxy-reported stroke and the risk of Alzheimer disease..  61:982. 2004
  • Donepezil use in Down syndrome..  61:605-606. 2004
  • Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study..  61:82-88. 2004
  • The parkinsonian phenotype of spinocerebellar ataxia type 2..  61:35-38. 2004
  • Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations..  60:1524-1534. 2003
  • Migraine headache in patients with Tourette syndrome..  60:1595-1598. 2003
  • Association study of Parkin gene polymorphisms with idiopathic Parkinson disease..  60:975-980. 2003
  • A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study..  59:1937-1943. 2002
  • Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies..  59:1870-1873. 2002
  • A functional magnetic resonance imaging study of left hemisphere language dominance in children..  59:1168-1174. 2002
  • Apolipoprotein E and neuromuscular disease: a critical review of the literature..  57:1561-1565. 2000
  • Botulinum toxin in the treatment of tics..  57:1190-1193. 2000
  • Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas..  57:846-851. 2000
  • The many faces of Charcot-Marie-Tooth disease..  57:638-640. 2000
  • Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease..  56:857-862. 1999
  • Domestic violence in neurologic practice..  56:659-660. 1999
  • Ictal cognitive assessment of partial seizures and pseudoseizures..  55:1456-1459. 1998
  • Potential effects of common drugs on stroke recovery..  55:454-456. 1998
  • Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995..  55:25-32. 1998
  • Genetic testing for Alzheimer disease. Practical and ethical issues..  54:1226-1229. 1997
  • D2 dopamine receptor A1 allele in Alzheimer disease and aging..  54:281-285. 1997
  • Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition..  53:418-422. 1996
  • Lipids and stroke: a paradox resolved..  53:303-308. 1996
  • Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias..  53:338-344. 1996
  • Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection..  53:148-153. 1996
  • Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance..  52:763-771. 1995
  • There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease..  52:650-651. 1995
  • Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele..  51:1189-1192. 1994
  • A molecular genetic study of intracerebral hemorrhage..  51:981-984. 1994
  • Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data..  51:916-921. 1994
  • Long-term survival of veterans with traumatic spinal cord injury..  50:909-914. 1993
  • Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs..  50:599-603. 1993
  • Neuropsychological importance of subcortical white matter hyperintensity..  49:1248-1252. 1992
  • Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease..  49:448-452. 1992
  • 'Haw River syndrome' or dentato-rubro-pallido-luysian atrophy?.  49:13-14. 1992
  • Evaluation of cerebral biopsies for the diagnosis of dementia..  49:28-31. 1992
  • Diagnostic criteria for multiple sclerosis research involving multiply affected families..  48:805-807. 1991
  • Estimated prevalence of dementia among elderly black and white community residents..  48:594-598. 1991
  • Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study..  48:613-617. 1991
  • Magnetic resonance imaging hyperintensities in Alzheimer's disease..  48:468-470. 1991
  • Magnetic resonance evaluation of the midbrain in Parkinson's disease..  48:360. 1991
  • Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures..  48:278-281. 1991
  • Aplasia cutis congenita and arteriovenous fistula. Case report and review..  47:1255-1258. 1990
  • Babinski's sign in Medieval, Renaissance, and Baroque art..  47:253. 1990
  • Sodium and water regulation in a patient with cerebral salt wasting..  46:928-930. 1989
  • Ataxia, chorea, seizures, and dementia. Pathologic features of a newly defined familial disorder..  46:774-779. 1989
  • Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders..  46:696-699. 1989
  • Interrater reliability of the NIH stroke scale..  46:660-662. 1989
  • Babinski's sign in medieval, Renaissance, and baroque art..  46:85-88. 1989
  • Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography..  45:687-690. 1988
  • Distal vacuolar myopathy with complete heart block..  45:698-699. 1988
  • Cardiovascular autonomic dysfunction in Guillain-Barré syndrome. Therapeutic implications of Swan-Ganz monitoring..  45:115-117. 1988
  • A multicenter study of anticoagulation parameters when using heparin and warfarin..  44:1229-1231. 1987
  • Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test..  44:924-927. 1987
  • Epidural morphine treatment of pain in Guillain-Barré syndrome..  43:1194-1196. 1986
  • Botulinum toxin in the management of blepharospasm..  43:380-382. 1986
  • Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature..  43:410-415. 1986
  • Childhood Guillain-Barré syndrome masquerading as a protracted pain syndrome..  42:839. 1985
  • Foster Kennedy syndrome..  41:658-659. 1984
  • Fibroblasts in Huntington's disease..  41:251. 1984
  • Late-onset Mcardle's disease with unusual electromyographic findings..  40:374-377. 1983
  • Thymectomy in late-onset myasthenia gravis..  39:82-83. 1982
  • CSF in herpes zoster meningoencephalitis..  38:668. 1981
  • Acquired reversible autistic syndrome in acute encephalopathic illness in children..  38:191-194. 1981
  • Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior..  37:749-753. 1980
  • Cylindroma causing Garcin's syndrome..  37:786. 1980
  • Familial carpal tunnel syndrome..  36:727. 1979
  • Cerebral vasculitis..  36:321. 1979
  • Tapia's syndrome. The erratic evolution of an eponym..  36:257-260. 1979
  • A quantitative comparison of the effects of various antibiotics on neuromuscular transmission.  36:252. 1979
  • Plasma exchange in the treatment of myasthenia gravis.  36:251. 1979
  • Menstrual meralgia..  35:549. 1978
  • Familial occurrence of meralgia paraesthetica..  35:182. 1978
  • Chemotherapy of brain tumors..  34:523-526. 1977
  • Experimental autoimmune myasthenia gravis in rats. Modification by thymectomy and prednisolone..  34:75-79. 1977
  • Myotonia congenita with painful muscle contractions..  33:580-582. 1976
  • Scanning electron microscopy studies in muscular dystrophy..  33:172-174. 1976
  • Congenital ichthyosis with spastic paraplegia of adult onset..  32:699-701. 1975
  • Familial hypokalemic periodic paralysis..  31:110-115. 1974
  • Sympathetic neural influence on norepinephrine vasoconstriction in brain vessels..  27:492-495. 1972
  • Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis..  24:365-373. 1971
  • The sylvian aqueduct syndrome. A clinicopathologic study..  15:215-222. 1966